Telcardis Plus 40 mg+12.5 mg (Tablet)

Indications

• Treatment of hypertension
• Lowering blood pressure
• Risk reduction for cardiovascular events

Pharmacology

• Angiotensin II inhibition
• Vasoconstriction blockade
• Diuretic effect
• Plasma volume reduction

Dosage & Administration

• Initial dose of Telmisartan monotherapy 80 mg
• Thiazide diuretic dose at 25 mg
• Possible titration to 160 mg/25 mg

Interaction

• Caution with aliskiren
• Potential interaction with NSAIDs
• Possible interference with some laboratory tests

Contraindications

• Hypersensitivity to Telmisartan or Hydrochlorothiazide
• Contraindicated in patients with known Aliskiren hypersensitivity

Side Effects

• Dizziness
• Drowsiness
• Flushing
• Nausea
• Back pain
• Diarrhea
• Elevated liver enzymes
• Leg cramps

Pregnancy & Lactation

• Pregnancy Category D
• Discontinuation during pregnancy
• Potential excretion in human milk

Precautions & Warnings

• Precaution in kidney and liver diseases
• Monitoring blood sugar
• Potential impact on body potassium levels

Use in Special Populations

• Safety and effectiveness in pediatric patients not established
• Cautious dose selection for elderly patients

Overdose Effects

• Manifestations like hypertension and dehydration
• Telmisartan not removed by hemodialysis

Therapeutic Class

• Combined antihypertensive preparations

Storage Conditions

• Keep in cool, dry place
• Protection from light

Related Brands

• Mitosan Plus 40 mg+12.5 mg (Tablet) - sandoz-a-novartis-division
• Mitosan Plus 80 mg+12.5 mg (Tablet) - sandoz-a-novartis-division